MED

Medifast, Inc. · NYSE · Consumer Cyclical · USD · 10-K for 2025, filed 2026-02-17

Figures on this page computed 2026-11-08 12:40 UTC

Last close

13.15USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-17

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-17
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
The filing itself
-4.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
The filing itself
0.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
The filing itself
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
The filing itself
0.1%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.04 against 0.44 on the market's range.

Five bars, one line

lens 7 of 9

0.49x

-0.28x

0.02x

1.10x

0.13x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-17

Sales0.49x
Its own average over 10 years, 791.1M.
Profit-0.28x
Its own average over 10 years, 67.3M.
Free cash flow0.02x
Its own average over 10 years, 73.0M.
Debt1.10x
Its own average over 5 years, 9.8M.
Price0.13x
Its own average over 11 years, 98. Market data, 2026-11-04

Profit is furthest from its own average, at -0.28 times.

Sales is 0.49 times its own 10-year average; Profit is -0.28 times its own 10-year average; Free cash flow is 0.02 times its own 10-year average; Debt is 1.09 times its own 5-year average; Price is 0.13 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-17

Sales against its own 10-year average0.49
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Profit against its own 10-year average-0.28
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Free cash flow against its own 10-year average0.02
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Debt against its own 5-year average1.10
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Price against its own 11-year average0.13Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD